Spectral Medical (EDT) Competitors C$0.50 -0.02 (-3.85%) (As of 11/21/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider Trades EDT vs. AKU, GEN, LMD, LXG, SQD, DXD, MBI, BUX, CRL, and GUDShould you be buying Spectral Medical stock or one of its competitors? The main competitors of Spectral Medical include Akumin (AKU), GeneNews (GEN), LED Medical Diagnostics (LMD), LexaGene (LXG), SQI Diagnostics (SQD), 3D Signatures (DXD), Med Biogene (MBI), Biomark Diagnostics (BUX), Charles River Laboratories International (CRL), and Knight Therapeutics (GUD). These companies are all part of the "medical" sector. Spectral Medical vs. Akumin GeneNews LED Medical Diagnostics LexaGene SQI Diagnostics 3D Signatures Med Biogene Biomark Diagnostics Charles River Laboratories International Knight Therapeutics Spectral Medical (TSE:EDT) and Akumin (TSE:AKU) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, risk, valuation, profitability, media sentiment, analyst recommendations, earnings, institutional ownership and dividends. Is EDT or AKU more profitable? Spectral Medical has a net margin of 0.00% compared to Akumin's net margin of -34.67%. Akumin's return on equity of -483.86% beat Spectral Medical's return on equity.Company Net Margins Return on Equity Return on Assets Spectral MedicalN/A -973.97% -93.22% Akumin -34.67%-483.86%0.47% Does the media refer more to EDT or AKU? In the previous week, Akumin had 1 more articles in the media than Spectral Medical. MarketBeat recorded 1 mentions for Akumin and 0 mentions for Spectral Medical. Spectral Medical's average media sentiment score of 0.00 equaled Akumin'saverage media sentiment score. Company Overall Sentiment Spectral Medical Neutral Akumin Neutral Which has better earnings and valuation, EDT or AKU? Spectral Medical has higher earnings, but lower revenue than Akumin. Spectral Medical is trading at a lower price-to-earnings ratio than Akumin, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpectral MedicalC$1.90M74.01-C$18.68M-C$0.07-7.14AkuminC$737.69M0.00-C$255.80M-C$3.80N/A Do insiders and institutionals have more ownership in EDT or AKU? 13.0% of Spectral Medical shares are owned by institutional investors. Comparatively, 30.3% of Akumin shares are owned by institutional investors. 18.2% of Spectral Medical shares are owned by insiders. Comparatively, 33.0% of Akumin shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Which has more volatility & risk, EDT or AKU? Spectral Medical has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500. Comparatively, Akumin has a beta of 0.15, indicating that its stock price is 85% less volatile than the S&P 500. Does the MarketBeat Community believe in EDT or AKU? Spectral Medical received 106 more outperform votes than Akumin when rated by MarketBeat users. Likewise, 65.17% of users gave Spectral Medical an outperform vote while only 64.10% of users gave Akumin an outperform vote. CompanyUnderperformOutperformSpectral MedicalOutperform Votes13165.17% Underperform Votes7034.83% AkuminOutperform Votes2564.10% Underperform Votes1435.90% SummaryAkumin beats Spectral Medical on 7 of the 13 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Spectral Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for EDT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EDT vs. The Competition Export to ExcelMetricSpectral MedicalDiagnostics & Research IndustryMedical SectorTSE ExchangeMarket CapC$140.63MC$26.98MC$5.14BC$6.38BDividend Yield1.45%5.44%5.05%5.71%P/E Ratio-7.141.91132.3726.51Price / Sales74.012,386.661,231.991,536.78Price / Cash82.5010.6040.0684.29Price / Book-6.252.556.953.15Net Income-C$18.68MC$49.27MC$119.48MC$300.21M7 Day Performance-10.71%3.03%-1.43%1.59%1 Month Performance-16.67%-2.80%-3.34%13.85%1 Year Performance23.46%8.14%32.33%49.61% Spectral Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EDTSpectral MedicalN/AC$0.50-3.8%N/A+36.8%C$140.63MC$1.90M-7.1429High Trading VolumeAKUAkuminN/AN/AN/AN/AC$37.20MC$737.69M-0.141,527News CoverageGENGeneNewsN/AN/AN/AN/AC$25.49MC$234,592.00-2.212,700LMDLED Medical DiagnosticsN/AC$0.40+∞N/A+0.0%C$15.51MC$14.96M-10.2646Gap UpLXGLexaGeneN/AC$0.11-19.2%N/A+0.0%C$14.77MC$110,927.00-1.3141High Trading VolumeSQDSQI DiagnosticsN/AC$0.02flatN/A+0.0%C$6.11MC$3.04M-0.30147,000Gap UpDXD3D SignaturesN/AC$0.04+∞N/A+0.0%C$2.66MN/A-0.91N/AGap UpMBIMed BiogeneN/AC$0.05-18.2%N/A+0.0%C$597,000.00N/A-7.5080Upcoming EarningsGap DownBUXBiomark DiagnosticsN/AN/AN/AN/A$0.00N/A0.00N/APositive NewsGap DownHigh Trading VolumeCRLCharles River Laboratories InternationalN/AN/AN/AN/A$0.00N/A0.0021,400Gap DownGUDKnight Therapeutics3.2117 of 5 starsC$5.30+1.7%C$7.08+33.6%-2.3%C$536.41MC$337.87M-26.50725Positive News Related Companies and Tools Related Companies Akumin Competitors GeneNews Competitors LED Medical Diagnostics Competitors LexaGene Competitors SQI Diagnostics Competitors 3D Signatures Competitors Med Biogene Competitors Biomark Diagnostics Competitors Charles River Laboratories International Competitors Knight Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:EDT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spectral Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spectral Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
